HomeBlog › Semaglutide vs Tirzepatide

Semaglutide vs Tirzepatide: Weight-Loss Shot Guide

GLP-1 receptor agonist medications have transformed the weight-loss landscape, offering a medically supervised path to significant, sustainable results. But with two leading options on the market—semaglutide (the active ingredient in Ozempic® and Wegovy®) and tirzepatide (the active ingredient in Mounjaro® and Zepbound®)—how do you know which one is right for you?

At LVB Body Sculpt MedSpa in Jefferson Valley, NY, we offer both compounded semaglutide and tirzepatide injections under board-certified medical oversight. This guide breaks down everything you need to know to make an informed decision with your provider.

Mechanism in a Minute

Both medications belong to the incretin-based therapy family, but they work through different hormonal pathways:

Feature Semaglutide Tirzepatide
Hormones targeted GLP-1 only GLP-1 + GIP (dual agonist)
Primary action Reduces appetite, slows gastric emptying Reduces appetite, slows gastric emptying, enhances insulin sensitivity
FDA approvals Type 2 diabetes (Ozempic), weight management (Wegovy) Type 2 diabetes (Mounjaro), weight management (Zepbound)

In plain terms: Semaglutide activates one hunger-regulating hormone (GLP-1). Tirzepatide activates two (GLP-1 and GIP), which is why some patients see faster or greater weight loss with the dual-agonist approach.

How Much Weight Can You Expect to Lose?

Clinical trials have demonstrated impressive results for both medications:

Metric Semaglutide (2.4 mg) Tirzepatide (15 mg)
Average body weight lost ~14.9% ~22.5%
Trial STEP 1 (68-week) SURMOUNT-1 (72-week)
Participants achieving ≥20% loss ~32% ~57%

Both medications significantly outperform diet and exercise alone. However, tirzepatide’s dual-hormone mechanism has consistently delivered higher average weight loss in head-to-head comparisons.

Speed of Results

Timeframe Semaglutide Tirzepatide
Noticeable appetite reduction 1–2 weeks 1–2 weeks
Measurable weight loss begins 4–6 weeks 2–4 weeks
Peak weight loss typically reached 60–68 weeks 60–72 weeks

Both medications require a gradual dose escalation over several weeks to minimize side effects. Your provider at LVB Body Sculpt MedSpa will adjust your dosing schedule based on your individual tolerance and progress.

Side-Effect Snapshot

The most common side effects for both medications are gastrointestinal and tend to be mild to moderate, especially during dose escalation:

Side Effect Semaglutide Tirzepatide
Nausea ~44% ~31%
Diarrhea ~30% ~23%
Vomiting ~24% ~12%
Constipation ~24% ~18%

Tirzepatide generally shows lower rates of nausea and vomiting in clinical trials, which can be an important factor for patients who are sensitive to GI side effects. Most side effects diminish as the body adjusts to the medication over the first few weeks.

Cardio-Metabolic Extras

Beyond weight loss, both medications offer additional health benefits:

Both medications may also help reduce inflammation and improve fatty liver markers, though these benefits are still being studied in larger trials.

Dosing & Convenience

Detail Semaglutide Tirzepatide
Injection frequency Once weekly Once weekly
Injection site Abdomen, thigh, or upper arm Abdomen, thigh, or upper arm
Dose escalation 4–5 dose levels over 16–20 weeks 3–4 dose levels over 12–20 weeks
Maintenance dose 2.4 mg weekly 5, 10, or 15 mg weekly

Both are simple, once-weekly subcutaneous injections. At LVB Body Sculpt MedSpa, we teach proper injection technique during your first visit and provide ongoing support throughout your treatment.

Who’s the Better Candidate for Each?

Factor Consider Semaglutide Consider Tirzepatide
Weight-loss goal Moderate (10–15% body weight) Aggressive (15–25% body weight)
Cardiovascular risk Established CVD (FDA-approved benefit) CVD outcome data pending
Blood sugar control Good improvement Superior improvement (type 2 diabetes)
GI sensitivity Can tolerate higher nausea rates Lower GI side-effect profile preferred
Prior GLP-1 use First-time GLP-1 user Plateaued on semaglutide or wants stronger response

Ultimately, the best medication is the one your provider recommends based on your complete medical history, metabolic profile, and personal goals. Schedule a free consultation to discuss which option is right for you.

How LVB Body Sculpt MedSpa Ensures Safety

Choosing where to get your weight-loss injections matters just as much as choosing which medication to use. At LVB Body Sculpt MedSpa, safety is built into every step:

Learn more about our GLP-1 weight loss program.

Frequently Asked Questions

What’s the difference between GLP-1 and GIP?

GLP-1 (glucagon-like peptide-1) is a hormone that reduces appetite, slows stomach emptying, and stimulates insulin release after eating. GIP (glucose-dependent insulinotropic polypeptide) is a second incretin hormone that enhances insulin secretion and may also play a role in fat metabolism. Semaglutide targets GLP-1 only, while tirzepatide targets both GLP-1 and GIP for a dual-action approach.

Can I switch from semaglutide to tirzepatide (or vice versa)?

Yes, under medical supervision. Some patients switch if they’ve plateaued on one medication or are experiencing persistent side effects. Your provider will manage the transition safely, including dose adjustments.

How long do I need to take the medication?

GLP-1 medications are most effective as part of an ongoing treatment plan. Stopping the medication often leads to weight regain. Your provider will work with you to determine the right long-term strategy, which may include a maintenance dose combined with lifestyle changes.

Are compounded versions safe?

When sourced from licensed, FDA-registered 503B compounding pharmacies—as we do at LVB Body Sculpt MedSpa—compounded semaglutide and tirzepatide meet strict quality, potency, and sterility standards. We never source from unverified or overseas suppliers.

Key Takeaways

  1. Both medications work. Semaglutide and tirzepatide are clinically proven to produce significant, sustained weight loss when combined with lifestyle changes.
  2. Tirzepatide tends to produce greater weight loss due to its dual GLP-1/GIP mechanism, though individual results vary.
  3. Tirzepatide generally has fewer GI side effects (lower nausea and vomiting rates) compared to semaglutide.
  4. Semaglutide has proven cardiovascular benefits for patients with established heart disease.
  5. The right choice depends on your medical profile, weight-loss goals, and how your body responds—which is why board-certified medical oversight is essential.

Ready to Clarify Your Path?

Choosing between semaglutide and tirzepatide doesn’t have to be overwhelming. Our medical team at LVB Body Sculpt MedSpa will evaluate your health history, run baseline labs, and recommend the medication that gives you the best chance of safe, lasting results.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a qualified healthcare provider. Individual results may vary. Always consult with your physician before starting any new medication or weight-loss program.

Start Your Weight-Loss Journey

Schedule a free consultation with our medical team. We’ll help you choose the right GLP-1 medication and create a personalized plan for lasting results.

Book a Consultation
Call (914) 639-2429 Book Now